Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network
Do the results of international clinical trials translate into a similar benefit for patients in South East Wales? The gene discussed is ERBB2; the disease is breast carcinoma.